![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
VIROLOGIC RESPONSE RATES ARE SIMILAR IN PREVIOUSLY UNTREATED AND PREVIOUSLY TREATED AND RELAPSED PATIENTS RECEIVING BOCEPREVIR TRIPLE THERAPY: A RETROSPECTIVE ANALYSIS
|
|
|
Reported by Jules Levin
EASL 2013 April 24-28 Amsterdam
Bruce Bacon1, Fred Poordad2, Jean-Pierre Bronowicki3, Rafael Esteban4, Seth Thompson5, Frans Helmond5
1Saint Louis University School of Medicine, St. Louis, MO, USA; 2University of Texas Health Science Center, San Antonio, TX, USA; 3Universitaire de Nancy, Vandoeuvre les Nancy, France; 4Hospital Universitari Valle Hebron, Barcelona, Spain; 5Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA
![EASL1.gif](../images/050613/050613-4/EASL1.gif)
![EASL2.gif](../images/050613/050613-4/EASL2.gif)
![EASL3.gif](../images/050613/050613-4/EASL3.gif)
![EASL4.gif](../images/050613/050613-4/EASL4.gif)
![EASL5.gif](../images/050613/050613-4/EASL5.gif)
![EASL6.gif](../images/050613/050613-4/EASL6.gif)
![EASL7.gif](../images/050613/050613-4/EASL7.gif)
![EASL8.gif](../images/050613/050613-4/EASL8.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|